NF1 and neoplasm: Although in vitro treatments showed some ability to attenuate RAS pathway signaling, administration of FTIs in vivo was not successful in preventing pNF tumor progression in mice (Mahgoub et al., 1999) or in clinical trials with children with NF1 (Widemann et al., 2014a,b).